These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8321360

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside.
    Gherardi E, Calandra S.
    Biochim Biophys Acta; 1982 Feb 15; 710(2):188-96. PubMed ID: 7066357
    [Abstract] [Full Text] [Related]

  • 4. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.
    Vaziri ND, Liang K, Parks JS.
    Am J Physiol Renal Physiol; 2001 May 15; 280(5):F823-8. PubMed ID: 11292624
    [Abstract] [Full Text] [Related]

  • 5. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
    Vaziri ND, Liang K.
    Am J Nephrol; 2004 May 15; 24(6):606-13. PubMed ID: 15583480
    [Abstract] [Full Text] [Related]

  • 6. [Effect of Astragalus Angelica Mixture on lipoprotein lipase and lecithin cholesterol acyltransferase of nephrotic rats].
    Li N, Li J, Xin G.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1999 Aug 15; 19(8):484-6. PubMed ID: 11783230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats.
    Joles JA, Willekes-Koolschijn N, Scheek LM, Koomans HA, Rabelink TJ, van Tol A.
    Kidney Int; 1994 Jul 15; 46(1):97-104. PubMed ID: 7933850
    [Abstract] [Full Text] [Related]

  • 9. [Disorders of lipid metabolism in patients with nephrotic syndrome].
    Zdrojewski Z.
    Pol Tyg Lek; 1994 Jul 15; 47(31-33):696-9. PubMed ID: 1492041
    [No Abstract] [Full Text] [Related]

  • 10. [Lipid metabolism in daunomycin-induced nephrotic rats (Part 6)].
    Gomikawa S, Inagaki O, Mori H, Inoue S, Takamitsu Y, Fujita Y.
    Nihon Jinzo Gakkai Shi; 1993 Mar 15; 35(3):239-46. PubMed ID: 8501853
    [Abstract] [Full Text] [Related]

  • 11. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E.
    Isr J Med Sci; 1996 Jun 15; 32(6):390-7. PubMed ID: 8682644
    [Abstract] [Full Text] [Related]

  • 12. High density lipoproteinuria in nephrotic syndrome.
    de Mendoza SG, Kashyap ML, Chen CY, Lutmer RF.
    Metabolism; 1976 Oct 15; 25(10):1143-9. PubMed ID: 184367
    [Abstract] [Full Text] [Related]

  • 13. On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis.
    al-Shurbaji A, Berglund L, Berge RK, Cederblad G, Humble E.
    Lipids; 1997 Aug 15; 32(8):847-52. PubMed ID: 9270976
    [Abstract] [Full Text] [Related]

  • 14. Regulation of plasma lipid levels by plasma viscosity in nephrotic rats.
    Yedgar S, Eilam O, Shafrir E.
    Am J Physiol; 1985 Jan 15; 248(1 Pt 1):E10-4. PubMed ID: 3966545
    [Abstract] [Full Text] [Related]

  • 15. Acyl-coenzyme A: cholesterol- acyl-coenzyme A:1,2-diacylglycerol acyltransferase and phosphatidate phosphorylase activities in liver microsomes from nephrotic rats.
    Agbedana EO, Yamamoto T, Moriwaki Y, Takahashi S, Suda M, Higashino K.
    Afr J Med Med Sci; 1996 Dec 15; 25(4):365-71. PubMed ID: 9532309
    [Abstract] [Full Text] [Related]

  • 16. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P, Kannan NK.
    J Pharm Pharmacol; 2006 Oct 15; 58(10):1373-83. PubMed ID: 17034661
    [Abstract] [Full Text] [Related]

  • 17. The lowering effect of probucol on plasma lipoprotein and proteinuria in puromycin aminonucleoside-induced nephrotic rats.
    Hirano T, Mamo JC, Nagano S, Sugisaki T.
    Nephron; 1991 Oct 15; 58(1):95-100. PubMed ID: 1857487
    [Abstract] [Full Text] [Related]

  • 18. Fluvastatin, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, suppresses very low-density lipoprotein secretion in puromycin aminonucleoside-nephrotic rats.
    Moritomo Y, Hirano T, Ebara T, Kurokawa M, Naito H, Furukawa S, Nagano S.
    Nephron; 1994 Oct 15; 67(2):218-25. PubMed ID: 8072613
    [Abstract] [Full Text] [Related]

  • 19. Low density lipoprotein metabolism in rats with puromycin aminonucleoside-induced nephrotic syndrome.
    Joven J, Masana L, Villabona C, Vilella E, Bargalló T, Trias M, Figueras M, Turner PR.
    Metabolism; 1989 May 15; 38(5):491-5. PubMed ID: 2725289
    [Abstract] [Full Text] [Related]

  • 20. Sterol regulatory element-binding proteins, liver X receptor, ABCA1 transporter, CD36, scavenger receptors A1 and B1 in nephrotic kidney.
    Kim HJ, Vaziri ND.
    Am J Nephrol; 2009 May 15; 29(6):607-14. PubMed ID: 19147991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.